The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shchepkin E.S.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Kasyanov E.D.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Yakovleva Ya.V.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Rukavishnikov G.V.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Kosterin D.N.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Pavlova L.V.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Gerasimchuk E.S.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Yanushko M.G.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Mazo G.E.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Association of hematological coefficients of inflammation using high-density lipoproteins in evaluating the severity of mood disorders

Authors:

Shchepkin E.S., Kasyanov E.D., Yakovleva Ya.V., Rukavishnikov G.V., Kosterin D.N., Pavlova L.V., Gerasimchuk E.S., Yanushko M.G., Mazo G.E.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2026;126(2): 116‑122

DOI: 10.17116/jnevro2026126021116

Read: 489 times

Buy for 300₽
Contact the author
Table of contents

ASSOCIATION OF HEMATOLOGICAL COEFFICIENTS OF INFLAMMATION USING HIGH-DENSITY LIPOPROTEINS IN EVALUATING THE SEVERITY OF MOOD DISORDERS
ASSOCIATION OF HEMATOLOGICAL COEFFICIENTS OF INFLAMMATION USING HIGH-DENSITY LIPOPROTEINS IN EVALUATING THE SEVERITY OF MOOD DISORDERS

To cite this article:

Shchepkin ES, Kasyanov ED, Yakovleva YaV, et al. Association of hematological coefficients of inflammation using high-density lipoproteins in evaluating the severity of mood disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;126(2):116‑122. (In Russ.)
https://doi.org/10.17116/jnevro2026126021116

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Cyto­kine status of patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):5-12
A comprehensive study of Alzheimer’s disease biomarkers in plasma and cere­brospinal fluid. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):43-53
Prospects for treating Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):54-60
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Asso­ciation of cortisol levels with psychopathological features of depression and therapeutic response in female patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):45-54
Proinflammatory cyto­kines — as a marker of the effe­ctiveness of neuroprotection in children with peri­natal nervous system damage. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):62-66
Asso­ciations of gene­tic poly­morphisms in key inflammatory response genes with the risk of chro­nic apical periodontitis deve­lopment. Russian Journal of Stomatology. 2025;(2):52-56
Diagnostic stra­tegies for post-COVID syndrome. Russian Journal of Preventive Medi­cine. 2025;(6):126-130
Spectral analysis in meta­bolomics of skin neoplasms. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):277-283
Embryological mechanisms of sexual orientation and gender identity diso­rders. Russian Journal of Human Reproduction. 2025;(3):34-41
Abstract:

OBJECTIVE

Exploratory analysis of associations of indicators of systemic inflammation and lipid metabolism in males and females with mood disorders.

MATERIAL AND METHODS

This retrospective study included 177 patients aged 18—60 years diagnosed with depressive episode/recurrent depressive disorder (DE/RDE) and bipolar affective disorder (BAD), of which 61.6% (n=109) were female. Patients were selected based on a review of medical records. From the medical records, data on age, gender, anthropometric indicators, and the results of the blood count (platelets, lymphocytes, neutrophils, monocytes) and blood chemistry (high-density lipoproteins — HDL) tests were collected, as well as the quantitative values of the Montgomery—Asberg Depression Rating Scale (MADRS) and the Young Mania Rating Scale (YMRS). Statistical analysis was performed in RStudio v2025.05.0+496.

RESULTS

The results of the correlation analysis showed a significant relationship (p<0.05) between gender and hematological inflammation coefficients (HIC), as well as between gender and the severity of affective symptoms. In females with DE/RDE, the severity of depression was moderately and negatively correlated with the ratio of monocytes to HDL, and a weak but statistically significant positive correlation was found in BAD patients. In addition, women with DE/RDE had significant moderate negative correlations between the severity of depression and the platelet to HDL ratio. In contrast, males with DE/RDE had a significant moderate positive correlation between the severity of depression and the lymphocyte to HDL ratio. There were no associations between the severity of mania and any HICs in patients of either gender.

CONCLUSION

Significant associations were found between indicators of inflammation and lipid metabolism, and affective disorders, with the strongest correlations observed in females.

Keywords:

gender
bipolar affective disorder
depressive disorder
neuroinflammation
cytokines
biomarkers

Authors:

Shchepkin E.S.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Kasyanov E.D.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Yakovleva Ya.V.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Rukavishnikov G.V.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Kosterin D.N.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Pavlova L.V.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Gerasimchuk E.S.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Yanushko M.G.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Mazo G.E.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Received:

14.07.2025

Accepted:

18.11.2025

Close metadata

References:

  1. Sforzini L, Worrell C, Kose M, et al. A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials. Molecular Psychiatry. 2022;27(3):1286-1299. https://doi.org/10.1038/s41380-021-01381-x
  2. Pastis I, Santos MG, Paruchuri A. Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis. Frontiers in Behavioral Neuroscience. 2024;17:1282242. https://doi.org/10.3389/fnbeh.2023.1282242
  3. Pirillo A, Catapano AL, Norata GD. Biological Consequences of Dysfunctional HDL. Current Medicinal Chemistry. 2019;26(9):1644-1664. https://doi.org/10.2174/0929867325666180530110543
  4. Almulla AF, Thipakorn Y, Algon AAA, et al. Reverse cholesterol transport and lipid peroxidation biomarkers in major depression and bipolar disorder: A systematic review and meta-analysis. Brain, Behavior, and Immunity. 2023;113:374-388.  https://doi.org/10.1016/j.bbi.2023.08.007
  5. Maes M, Smith R, Christophe A, et al. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatrica Scandinavica. 1997;95(3):212-221.  https://doi.org/10.1111/j.1600-0447.1997.tb09622.x
  6. Guo J, Qian X, Yan R, et al. Serum albumin levels and depression symptoms: data from the National Health and Nutrition Examination Survey (NHANES) 2005–2018. Frontiers in Public Health. 2023;11:1161186.
  7. Gao H, Liu Y, Li Q, et al. Association between lipid metabolism biomarkers and depressive symptoms in adults: evidence from NHANES 2017–2020. Lipids in Health and Disease. 2024;23(1):77.  https://doi.org/10.1186/s12944-024-02204-y
  8. Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Molecular Psychiatry. 2016;21(12):1696-1709. https://doi.org/10.1038/mp.2016.3
  9. Dickerson F, Severance E, Yolken R. The microbiome, immunity, and schizophrenia and bipolar disorder. Brain, Behavior, and Immunity. 2017;62:46-52.  https://doi.org/10.1016/j.bbi.2016.12.010
  10. Sayana P, Colpo GD, Simões LR, et al. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients. Journal of Psychiatric Research. 2017;92:160-182.  https://doi.org/10.1016/j.jpsychires.2017.03.018
  11. Morris G, Puri BK, Bortolasci CC, et al. The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders. Neuroscience and biobehavioral reviews. 2021;125:244-263.  https://doi.org/10.1016/j.neubiorev.2021.02.037
  12. Jha M, Leboyer M, Pariante C, et al. Should Inflammation Be a Specifier for Major Depression in the DSM-6? JAMA Psychiatry. 2025;82:549-550.  https://doi.org/10.1001/jamapsychiatry.2025.0206
  13. Milaneschi Y, Kappelmann N, Ye Z, et al. Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts. Molecular Psychiatry. 2021;26(12):7393-7402. https://doi.org/10.1038/s41380-021-01188-w
  14. Slavich GM, Sacher J. Stress, sex hormones, inflammation, and major depressive disorder: Extending Social Signal Transduction Theory of Depression to account for sex differences in mood disorders. Psychopharmacology (Berlin). 2019;236(10):3063-3079. https://doi.org/10.1007/s00213-019-05326-9
  15. Lombardo G, Mondelli V, Worrell C, et al. Disturbed sex hormone milieu in males and females with major depressive disorder and low-grade inflammation. Journal of Affective Disorders. 2024;356:167-176.  https://doi.org/10.1016/j.jad.2024.03.018
  16. Piepenburg SM, Faller H, Störk S, et al. Symptom patterns and clinical outcomes in women versus men with systolic heart failure and depression. Clinical Research in Cardiology. 2019;108(3):244-253.  https://doi.org/10.1007/s00392-018-1348-6
  17. Salk RH, Hyde JS, Abramson LY. Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms. Psychological Bulletin. 2017;143(8):783-822.  https://doi.org/10.1037/bul0000102
  18. Gorbunova AP, Rukavishnikov GV, Mazo GE. Inflammation as a link between depression and metabolic syndrome. V.M. Bekhterev review of psychiatry and medical psychology. 2024;58(4-2):8-19. (In Russ.). https://doi.org/10.31363/2313-7053-2024-1005
  19. Cheng N, Ma L, Ren Y, et al. The Predictive Value of Monocyte/High-Density Lipoprotein Ratio (MHR) and Positive Symptom Scores for Aggression in Patients With Schizophrenia. International Journal of Neuropsychopharmacology. 2023;26(5):399-408.  https://doi.org/10.1093/ijnp/pyad014
  20. Qiu M, Zhang C, Zhang H, et al. Retrospective evaluation of novel serum inflammatory biomarkers in first-episode psychiatric disorders: diagnostic potential and immune dysregulation. Frontiers in Psychiatry. 2024;15:1442954. https://doi.org/10.3389/fpsyt.2024.1442954
  21. Neznanov NG, Mazo GE, Kibitov AO, et al. Atypical depression: from phenotype to endophenotype. Socialʹnaâ i kliničeskaâ psihiatriâ. 2016;26(3):5-16. (In Russ.).
  22. Rodgers S, Vandeleur CL, Ajdacic-Gross V, et al. Tracing the associations between sex, the atypical and the combined atypical-melancholic depression subtypes: A path analysis. Journal of Affective Disorders. 2016;190:807-818.  https://doi.org/10.1016/j.jad.2015.10.067
  23. Shchepkin ES, Kasyanov ED, Yakovleva YAV, et al. Differences in the structure of episodes and concomitant disorders in men and women with bipolar and depressive disorders. Socialʹnaâ i kliničeskaâ psihiatriâ. 2024;34(4):5-16. (In Russ.).
  24. Łojko D, Buzuk G, Owecki M, et al. Atypical features in depression: Association with obesity and bipolar disorder. Journal of Affective Disorders. 2015;185:76-80.  https://doi.org/10.1016/j.jad.2015.06.020
  25. Ni J, Wu P, Lu X, et al. Examining the cross-sectional relationship of platelet/high-density lipoprotein cholesterol ratio with depressive symptoms in adults in the United States. BMC Psychiatry. 2024;24(1):427.  https://doi.org/10.1186/s12888-024-05878-x
  26. Amitai M, Kaffman S, Kroizer E, et al. Neutrophil to-lymphocyte and platelet-to-lymphocyte ratios as biomarkers for suicidal behavior in children and adolescents with depression or anxiety treated with selective serotonin reuptake inhibitors. Brain, Behavior, and Immunity. 2022;104:31-38.  https://doi.org/10.1016/j.bbi.2022.04.018
  27. Zhang H, Xu Y, Xu Y. The value of the platelet/high-density lipoprotein cholesterol ratio in predicting depression and its cardiovascular disease mortality: a population-based observational study. Frontiers in Endocrinology (Lausanne). 2024;15:1402336. https://doi.org/10.3389/fendo.2024.1402336
  28. Su M, Ouyang X, Song Y. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and monocyte to lymphocyte ratio in depression: A meta-analysis. Journal of Affective Disorders. 2022;308:375-383.  https://doi.org/10.1016/j.jad.2022.04.038
  29. Chen J, Huang Y, Li X. The association between lymphocyte to high-density lipoprotein ratio and depression: Data from NHANES 2015-2018. Brain and Behavior. 2024;14(3):e3467. https://doi.org/10.1002/brb3.3467
  30. Chen H, Xiong C, Shao X, et al. Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome. Diabetes, Metabolic Syndrome and Obesity. 2019;12:2117-2123. https://doi.org/10.2147/DMSO.S219363
  31. Yu S, Guo X, Li G, et al. Lymphocyte to High-Density Lipoprotein Ratio but Not Platelet to Lymphocyte Ratio Effectively Predicts Metabolic Syndrome Among Subjects From Rural China. Frontiers in Cardiovascular Medicine. 2021;8:583320. https://doi.org/10.3389/fcvm.2021.583320
  32. Beurel E, Lowell JA, Jope RS. Distinct characteristics of hippocampal pathogenic TH17 cells in a mouse model of depression. Brain, Behavior, and Immunity. 2018;73:180-191.  https://doi.org/10.1016/j.bbi.2018.04.012
  33. Wilhelm AJ, Zabalawi M, Owen JS, et al. Apolipoprotein A-I modulates regulatory T cells by activating mitochondrial metabolism. Journal of Clinical Investigation. 2016;126(10):3822-3832.
  34. Kim JW, Kim YK, Hwang JA, et al. Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder. Psychiatry Investigation. 2013;10(3):294-299.  https://doi.org/10.4306/pi.2013.10.3.294
  35. Ganança L, Galfalvy HC, Cisneros-Trujillo S, et al. Relationships between inflammatory markers and suicide risk status in major depression. Journal of Psychiatric Research. 2021;134:192-199.  https://doi.org/10.1016/j.jpsychires.2020.12.029
  36. Hu S, Gu Y, Lu Z, et al. Relationship Between Grip Strength and Prediabetes in a Large-Scale Adult Population. American Journal of Preventive Medicine. 2019;56(6):844-851.  https://doi.org/10.1016/j.amepre.2019.01.013
  37. Xu H, Li R, Wang L, et al. Non-enzymatic antioxidants, macro-minerals and monocyte/high-density lipoprotein cholesterol ratio among patients with bipolar disorder. Journal of Affective Disorders. 2023;322:76-83.  https://doi.org/10.1016/j.jad.2022.11.017
  38. Uyar B, Ateş Budak E. Effects of Major Depressive Disorder on Monocytes, High-Density Lipoprotein (HDL) and Monocyte to HDL Ratio: A Case-Control Study. Psychiatria Danubina. 2022;34(4):687-694.  https://doi.org/10.24869/psyd.2022.687
  39. Korkmaz ŞA, Kızgın S. Neutrophil/high-density lipoprotein cholesterol (HDL), monocyte/HDL and platelet/HDL ratios are increased in acute mania as markers of inflammation, even after controlling for confounding factors. Current Medical Research and Opinion. 2023;39(10):1383-1390. https://doi.org/10.1080/03007995.2023.2260302
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.